Transcorneal electrical stimulation for the treatment of retinitis pigmentosa: results from the TESOLAUK trial.

ABSTRACT:

Objective

To explore the impact of weekly transcorneal electrical stimulation (TES) over a 6-month period as a treatment for retinitis pigmentosa (RP).

Methods and analysis

A prospective open-label observational trial was carried out assessing weekly TES in participants with RP for a period of 6 months followed by observation for a further 6 months. Clinical examination and investigations were carried out at 3 monthly intervals for a total of 12 months. The primary outcome measure explored safety through a descriptive analysis of adverse effects with secondary outcome measures evaluating structural and functional efficacy.

Results

Seven male and seven female participants with RP aged 18-80 years were recruited. TES was well tolerated with no serious adverse events rep

SUBMITTER: Wagner SK 

PROVIDER: S-EPMC5751865 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature